Matches in Wikidata for { <http://www.wikidata.org/entity/Q28565493> ?p ?o ?g. }
- Q28565493 description "2011 թուականի Մարտին հրատարակուած գիտական յօդուած" @default.
- Q28565493 description "2011 թվականի մարտին հրատարակված գիտական հոդված" @default.
- Q28565493 description "article scientifique publié en 2011" @default.
- Q28565493 description "artículu científicu espublizáu en 2011" @default.
- Q28565493 description "im März 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q28565493 description "scientific journal article" @default.
- Q28565493 description "vedecký článok (publikovaný 2011/03/01)" @default.
- Q28565493 description "vědecký článek publikovaný v roce 2011" @default.
- Q28565493 description "wetenschappelijk artikel (gepubliceerd op 2011/03/01)" @default.
- Q28565493 description "наукова стаття, опублікована в березні 2011" @default.
- Q28565493 description "مقالة علمية (نشرت في مارس 2011)" @default.
- Q28565493 name "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 name "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 name "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 type Item @default.
- Q28565493 label "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 label "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 label "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 prefLabel "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 prefLabel "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 prefLabel "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 P1433 Q28565493-05CE004F-9DA6-4D2F-824F-85FDB8291050 @default.
- Q28565493 P1476 Q28565493-2524740B-6AAA-4AAE-9C22-6E086B432B3E @default.
- Q28565493 P2093 Q28565493-0A88851D-F7F0-4D60-BBF9-BA9F77F817BB @default.
- Q28565493 P2093 Q28565493-3B673AB4-24B1-44AC-936B-DEEB1CABB9D9 @default.
- Q28565493 P2093 Q28565493-3B72142C-FBD8-4441-B9FF-8D98AD2E7F6E @default.
- Q28565493 P2093 Q28565493-9B7E9BA5-6139-4CE3-B52F-3F2B65FCBD8B @default.
- Q28565493 P2093 Q28565493-CA278FDE-2510-4B3B-AF75-05B4D58F345D @default.
- Q28565493 P2093 Q28565493-D7661051-2660-488C-A6F5-778D9C4F0640 @default.
- Q28565493 P2860 Q28565493-00ACC72C-63EC-4179-B74D-19F3EC5870E3 @default.
- Q28565493 P2860 Q28565493-05FF1D0D-F0EC-4859-968C-667457D061B2 @default.
- Q28565493 P2860 Q28565493-09421D1F-3659-4BC9-88D4-10B88C786268 @default.
- Q28565493 P2860 Q28565493-0CABA041-286C-4EE9-9420-819B58BF4942 @default.
- Q28565493 P2860 Q28565493-10503C0A-8337-4C8E-AE98-DA4C6E438BD7 @default.
- Q28565493 P2860 Q28565493-10AE63BE-C48A-4DE0-BD77-B1953344C664 @default.
- Q28565493 P2860 Q28565493-16D512D8-E852-46F5-9899-3830842B6EE9 @default.
- Q28565493 P2860 Q28565493-1F9C2910-608B-44F6-B6F9-CE13B01F8679 @default.
- Q28565493 P2860 Q28565493-1FD53006-CE44-43E0-ACEC-9B45AB7C8089 @default.
- Q28565493 P2860 Q28565493-248D27C7-3EC1-4D46-B054-456C16F6C917 @default.
- Q28565493 P2860 Q28565493-26276689-B645-4996-B2F1-68A8E35EBF87 @default.
- Q28565493 P2860 Q28565493-2A2DFC12-5F4E-434F-B66B-14EE1D03C33D @default.
- Q28565493 P2860 Q28565493-3A8E1922-46B9-49D9-8EFD-56035925F382 @default.
- Q28565493 P2860 Q28565493-3A9B77E6-F4B3-48FC-B5BF-B62273E2A293 @default.
- Q28565493 P2860 Q28565493-501AD41B-1D64-469F-8CDC-2FCEA72D9E0C @default.
- Q28565493 P2860 Q28565493-561437A4-F33D-4207-8D5A-2CF7B15B0001 @default.
- Q28565493 P2860 Q28565493-5E39D7C6-D9D3-428E-9470-D2017DC760F9 @default.
- Q28565493 P2860 Q28565493-64D1BD2C-01B0-4A96-9BAC-B78CBFBBF9E6 @default.
- Q28565493 P2860 Q28565493-64FBE101-BD5E-4250-B04D-1BB44CCF1972 @default.
- Q28565493 P2860 Q28565493-6879239D-8B29-4C08-9808-FABF9F97F3DD @default.
- Q28565493 P2860 Q28565493-68FF9D0B-4025-4BD4-8A47-DB27EF39B037 @default.
- Q28565493 P2860 Q28565493-6A655A8B-294A-4AF4-8EB2-5CEBD26003FB @default.
- Q28565493 P2860 Q28565493-6DBD64BB-C0DE-45AD-AAAB-764B14F6F63F @default.
- Q28565493 P2860 Q28565493-75B0BDE9-4D22-473B-BEC5-8ADDA97A073B @default.
- Q28565493 P2860 Q28565493-76E205DE-1738-498C-98AD-A209897A2A92 @default.
- Q28565493 P2860 Q28565493-83AD28A7-6513-4EBB-B8B3-55B332B0F9A8 @default.
- Q28565493 P2860 Q28565493-96AEB74B-A376-4EEC-9CBD-38C6F817596D @default.
- Q28565493 P2860 Q28565493-9B4794A3-B5E1-41D9-9107-C350090FA46E @default.
- Q28565493 P2860 Q28565493-9EAAAA9E-DF65-4F89-A542-5B09F03D9D3C @default.
- Q28565493 P2860 Q28565493-A03F9AD2-9C75-45EC-8000-237454A8F4A1 @default.
- Q28565493 P2860 Q28565493-A5C80957-716B-4389-BBC5-02D16FE91DB3 @default.
- Q28565493 P2860 Q28565493-A7296D7B-16A8-44E8-8CA5-EAD360BDA00A @default.
- Q28565493 P2860 Q28565493-A81F93B4-30B7-444D-9212-4FE8B494397D @default.
- Q28565493 P2860 Q28565493-ACF41985-46F2-4EAD-AA67-F6051C6E566E @default.
- Q28565493 P2860 Q28565493-B0EEBC73-1EE7-4136-B2B5-7490605D9BD8 @default.
- Q28565493 P2860 Q28565493-B132A12E-E4E6-45C1-A3BC-982424CF1012 @default.
- Q28565493 P2860 Q28565493-B3AA4C72-662B-4870-9B35-22EB5209B570 @default.
- Q28565493 P2860 Q28565493-C34C2F75-E082-45FA-9484-151BB83BAC53 @default.
- Q28565493 P2860 Q28565493-CC49AC9E-7D73-424B-A9E7-86AF8B7D95F3 @default.
- Q28565493 P2860 Q28565493-D071BADC-3F49-447C-86AD-F405A89D84CA @default.
- Q28565493 P2860 Q28565493-E0AAF1AC-470F-4348-8E27-9C2A0B6577B2 @default.
- Q28565493 P2860 Q28565493-E2863BB1-4D34-464C-A3CE-CB5238F99273 @default.
- Q28565493 P2860 Q28565493-E2EA34F7-155B-4411-B115-EF8416F36AAF @default.
- Q28565493 P304 Q28565493-1F9E3741-439A-49A5-AACC-64ED6BD83EBF @default.
- Q28565493 P31 Q28565493-F7674F07-06E2-4318-B656-B16A0C1B7CA9 @default.
- Q28565493 P356 Q28565493-AE22A3D5-2044-4450-A691-D31EAC74E933 @default.
- Q28565493 P407 Q28565493-0A607353-A151-4C63-9C33-E95BAC90E08B @default.
- Q28565493 P433 Q28565493-AB1939D0-68C7-4FB6-89F4-06436489AE54 @default.
- Q28565493 P478 Q28565493-F787DA47-C6A3-4E8F-AE3D-6C10CDBE706E @default.
- Q28565493 P577 Q28565493-6627657A-036A-4017-BCA0-47A5F7E09779 @default.
- Q28565493 P698 Q28565493-5E105082-5635-427F-B278-6AAC0446B519 @default.
- Q28565493 P921 Q28565493-19DCD45B-1D49-46B3-8FCC-F477F844F6BA @default.
- Q28565493 P921 Q28565493-A96FB421-8860-4590-850B-9ED83D8365B5 @default.
- Q28565493 P932 Q28565493-E8EAC792-38CE-4B45-9474-9ED358A1B585 @default.
- Q28565493 P356 HYPERTENSIONAHA.110.165704 @default.
- Q28565493 P698 21282555 @default.
- Q28565493 P1433 Q5958695 @default.
- Q28565493 P1476 "Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis" @default.
- Q28565493 P2093 "Hiroyuki Kobori" @default.
- Q28565493 P2093 "Kayoko Miyata" @default.
- Q28565493 P2093 "Maki Urushihara" @default.
- Q28565493 P2093 "Naro Ohashi" @default.
- Q28565493 P2093 "Omar W. Acres" @default.
- Q28565493 P2093 "Ryousuke Satou" @default.
- Q28565493 P2860 Q28360398 @default.
- Q28565493 P2860 Q33592898 @default.
- Q28565493 P2860 Q33610487 @default.
- Q28565493 P2860 Q33658799 @default.
- Q28565493 P2860 Q34150690 @default.
- Q28565493 P2860 Q34307448 @default.
- Q28565493 P2860 Q35102859 @default.